全文获取类型
收费全文 | 68898篇 |
免费 | 5093篇 |
国内免费 | 370篇 |
专业分类
耳鼻咽喉 | 691篇 |
儿科学 | 1789篇 |
妇产科学 | 1850篇 |
基础医学 | 8571篇 |
口腔科学 | 1713篇 |
临床医学 | 7018篇 |
内科学 | 15477篇 |
皮肤病学 | 917篇 |
神经病学 | 5364篇 |
特种医学 | 2063篇 |
外国民族医学 | 2篇 |
外科学 | 10519篇 |
综合类 | 1182篇 |
现状与发展 | 1篇 |
一般理论 | 105篇 |
预防医学 | 5493篇 |
眼科学 | 2042篇 |
药学 | 4916篇 |
中国医学 | 227篇 |
肿瘤学 | 4421篇 |
出版年
2023年 | 309篇 |
2022年 | 426篇 |
2021年 | 1303篇 |
2020年 | 808篇 |
2019年 | 1152篇 |
2018年 | 1423篇 |
2017年 | 961篇 |
2016年 | 1098篇 |
2015年 | 1323篇 |
2014年 | 1972篇 |
2013年 | 3104篇 |
2012年 | 4245篇 |
2011年 | 4545篇 |
2010年 | 2575篇 |
2009年 | 2406篇 |
2008年 | 4363篇 |
2007年 | 4511篇 |
2006年 | 4340篇 |
2005年 | 4392篇 |
2004年 | 4096篇 |
2003年 | 3670篇 |
2002年 | 3594篇 |
2001年 | 898篇 |
2000年 | 822篇 |
1999年 | 842篇 |
1998年 | 776篇 |
1997年 | 659篇 |
1996年 | 526篇 |
1995年 | 510篇 |
1994年 | 488篇 |
1993年 | 458篇 |
1992年 | 643篇 |
1991年 | 591篇 |
1990年 | 496篇 |
1989年 | 500篇 |
1988年 | 460篇 |
1987年 | 421篇 |
1986年 | 396篇 |
1985年 | 461篇 |
1984年 | 464篇 |
1983年 | 412篇 |
1982年 | 548篇 |
1981年 | 453篇 |
1980年 | 495篇 |
1979年 | 318篇 |
1978年 | 336篇 |
1977年 | 332篇 |
1976年 | 268篇 |
1975年 | 290篇 |
1974年 | 252篇 |
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
1.
Objective
The aim of the study was to estimate the effect of the state-based reinsurance programs through the section 1332 State Innovation Waivers on health insurance marketplace premiums and insurer participation.Data Source
2015 to 2022 Robert Wood Johnson Foundation Health Insurance Exchange Compare Datasets.Study Design
An event study difference-in-differences (DD) model separately for each year of implementation and a synthetic control method (SCM) are used to estimate year-by-year effects following program implementation.Data Collection/Extraction Methods
Not applicable.Principal Findings
Reinsurance programs were associated with a decline in premiums in the first year of implementation by 10%–13%, 5%–19%, and 11%–17% for bronze, silver, and gold plans (p < 0.05). There is a trend of sustained declines especially for states that implemented their programs in 2019 and 2020. The SCM analyses suggest some effect heterogeneity across states but also premium declines across most states. There is no evidence that reinsurance programs affected insurer participation.Conclusion
State-based reinsurance programs have the potential to improve the affordability of health insurance coverage. However, reinsurance programs do not appear to have had an effect on insurer participation, highlighting the need for policy makers to consider complementary strategies to encourage insurer participation. 相似文献2.
Rajendrababu Sharmila Puthuran George Varghese Alia Laxmi Ananya Uduman Mohammed Sithiq Wijesinghe Hiruni Kaushalya 《International ophthalmology》2022,42(8):2609-2618
International Ophthalmology - To investigate the efficacy and safety of non-valved Aurolab aqueous drainage implant (AADI) surgery combined with phacoemulsification in eyes with refractory glaucoma... 相似文献
3.
Her-Shyong Shiah Nai-Jung Chiang Chia-Chi Lin Chia-Jui Yen Hui-Jen Tsai Shang-Yin Wu Wu-Chou Su Kwang-Yu Chang Ching-Chiung Wang Jang-Yang Chang Li-Tzong Chen 《The oncologist》2021,26(4):e567-e579
Lessons Learned
- SCB01A is a novel microtubule inhibitor with vascular disrupting activity.
- This first‐in‐human study demonstrated SCB01A safety, pharmacokinetics, and preliminary antitumor activity.
- SCB01A is safe and well tolerated in patients with advanced solid malignancies with manageable neurotoxicity.
4.
5.
6.
7.
8.
9.
10.
Matrine,oxymatrine, and compound Kushen injection from the roots of Sophora flavescens: an overview of their anticancer activities 下载免费PDF全文
In the present review, we updated current information on the chemistry, contents, and anticancer properties of matrine (MT), oxymatrine (OMT), and compound Kushen injection (CKI). The anticancer properties were focused on lung, breast, and liver cancer cells because they are most susceptible. Sources of information were from Google, Google Scholar, PubMed, PubMed Central, Science Direct, PubChem, J-Stage, Directory of Open Access Journals (DOAJ), and China National Knowledge Infrastructure (CNKI). Reference was also made on botanical websites, such as Flora of China and World Flora Online. MT and OMT are dominant quinolizidine alkaloids from the roots of Sophora flavescens (Kushen) of the family Fabaceae. Against lung, breast, and liver cancer cells, MT and OMT inhibit cell proliferation; induce cell cycle arrest, apoptosis, and autophagy; restrict angiogenesis; and inhibit cell metastasis, invasion, and migration. The processes involve various molecular targets and signaling pathways. CKI is a traditional Chinese medicine (TCM) composed of root extracts of S. flavescens and Smilax glabra (Baituling) of the family Smilacaceae. With MT and OMT as major components, CKI has been approved for the treatment of cancer in China more than 20 years ago. In recent years, systematic reviews and meta-analysis have been undertaken to evaluate the anticancer effects of CKI. When CKI is used alone and in combination with chemotherapy of western medicine, there is much to be learned concerning their interactions besides their individual and integrated efficacy. Some perspectives of MT, OMT, and CKI are discussed, and their suggestions for future research are provided. 相似文献